The largest database of trusted experimental protocols

Discovery xt biomarker platform

Manufactured by Roche
Sourced in United States

The Discovery XT biomarker platform is a laboratory equipment product developed by Roche. It is designed to facilitate the detection and analysis of biomarkers, which are molecules that can indicate the presence or progression of a particular disease or condition. The platform provides researchers and clinicians with the tools to perform various assays and tests, enabling them to gather valuable data and insights. The core function of the Discovery XT is to support the identification and measurement of biomarkers, which can contribute to advancements in medical research and diagnostic applications.

Automatically generated - may contain errors

6 protocols using discovery xt biomarker platform

1

Histological and Immunohistochemical Analysis of Raman Imaging Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
After Raman imaging, the tissues were fixed in 4% paraformaldehyde (4 °C overnight) and subsequently processed to be embedded in paraffin. Tissue sections (5 μm) were stained with hematoxylin and eosin (H&E), and immunohistochemistry staining was performed using the DISCOVERY XT biomarker platform (Ventana, Tucson, AZ, USA). Heat-induced epitope retrieval was performed using citrate buffer (pH 6.0). The primary antibodies were diluted as follows: anti-CD44 antibody (1:500; #550538; BD Biosciences, San Jose, CA, USA), anti-Ki-67 antibody (1:250, VP-RM04, Vector Laboratories Inc., Burlingame, CA, USA), anti-CCND1 antibody (1:500; Abcam, Cambridge, MA, USA), and anti-PEG antibody (1:100, PEG-B-47, ab51257, Abcam). All biotin-labeled secondary antibodies, including anti-rabbit antibody (1:300, BA-1000) and anti-rat antibody (1:300, BA-9400), were purchased from Vector Laboratories. All murine specimens were examined by a veterinary pathologist (JRW) from the Tri-Institutional Laboratory of Comparative Pathology who was blinded to the Raman images. All rat specimens were examined by a pathologist (MvdR) from the Department of Pathology at Stanford University who was blinded to the Raman images.
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of SPINK1 and ERG

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining was applied using a commercially available antibody for SPINK1 (clone 4D4, 1:100 dilution, Abnova) and ERG (clone EPR 3864, 1:100 dilution, Epitomics) on the Discovery XT biomarker platform (Ventana Medical Systems, Inc.) (Figure 1). Semi-quantitative evaluation of cytoplasmic SPINK1 expression and nuclear ERG expression were separately performed. Staining of ≥5% of tumor cells was considered positive for each case.
+ Open protocol
+ Expand
3

Multimodal Imaging of Glioblastoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Intact GBM-bearing brains were sliced coronally (1 mm slice thickness) and embedded in paraffin. 5 μm-thick continuous sections were cut for hematoxylin and eosin (H&E) staining and immunohistochemistry (IHC) staining, followed by high-resolution Raman imaging on paraffin blocks. IHC staining was performed on the Discovery XT biomarker platform (Ventana, Tucson, AZ) as previously described 30 . Antibodies for OLIG2 (1:300, AB9610, Millipore, Temecula, CA), polyethylene glycol (1:100, ab51257, Abcam, Cambridge, MA), ITGB3 (1:100, 13166, Cell Signaling, Danvers, MA), ITGAV (1:2000, ab76609, Abcam), HA-tag (1:200, 11867423001, Roche, San Francisco, CA), IBA1 (1:600, 019-19741, Wako, Richmond, VA), NOS3 (1:200, 610296, BD Biosciences, Franklin Lakes, NJ) and ACTA2 (1:350, M0851, DAKO, Carpinteria, CA) were used as the primary antibodies. The slides were digitally scanned with Pannoramic Flash (3DHistech, Hungary) and relevant tissue areas were exported into tiff format. Quantification of Olig2 was performed using ImageJ/FIJI (NIH). Color deconvolution algorithm was used to determine the area of positive signal, which was normalized to tissue area.
+ Open protocol
+ Expand
4

Immunohistochemical Analysis of Olig2 in Brain Tumor Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
Brain tissues after tumor resections were embedded in paraffin. Hematoxylin and eosin staining and immunohistochemistry (IHC) staining were performed on 5 μm-thick sections. The Discovery XT biomarker platform (Ventana, Tucson, AZ) was used for IHC staining of Olig2. Antigen was retrieved using the heat-induced antigen unmasking technique in citrate-based buffer (pH 6.0). Anti-Olig-2 (1:300, AB9610, Millipore, Temecula, CA) and biotin-labeled anti-rabbit antibody (1:300, BA-1000, Vector Laboratories, Burlingame, CA) were used as the primary and secondary antibodies, respectively. Streptavidin–biotin peroxidase was visualized by the Discovery DAB map detection kit (760-124, Ventana).
+ Open protocol
+ Expand
5

Immunohistochemical Analysis of SLC6A2/NET

Check if the same lab product or an alternative is used in the 5 most similar protocols
The neuroblastoma xenografts were collected from the imaging studies and fixed by formalin. Paraffin-embedded tissue sections (5 μm) were immunostained using the Discovery XT biomarker platform (Ventana, Tucson, AZ). The primary antibody, anti-SLC6A2/NET polyclonal antibody (MBL, BMP029, Nagoya, Japan), was diluted at 1:100. Biotin-labeled anti-rabbit antibody (1:300, BA-1000, Vector Laboratories, Burlingame, CA) was used as the secondary antibody.
+ Open protocol
+ Expand
6

Multiplexed Immunohistochemistry for Breast Cancer Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paraffin-embedded human breast tissue sections and PDX were deparaffinized in xylene and rehydrated in graded alcohol. Immunohistochemistry was performed on a Ventana Discovery XT biomarker platform. For Ki-67 and cleaved-caspase-3 staining, antigen enhancement was performed by incubating the sections in citrate buffer, pH 6 (Dakocytomation). Staining was done using Peroxidase histostain-Plus Kit (Zymed) according to the manufacturer’s protocol. Ki-67 antibody (#R626, RTU, Agilent) and cleaved-caspase 3 (#9661 S, RTU, Cell Signaling) was used. DAB (Zymed) was used as substrate for peroxidase. For the multiplexed immunostaining of ALDH1 and γH2AX, we start with the anti-ALDH1 (mAb clone 44, Becton Dickinson, 1/50) antibody followed with the anti-γH2AX antibody (mAb JBW301, Merck Millipore, 1/2000). Multiplex staining was performed using Discovery OmniMap Multimer HRP with DAB substrate (Ventana) for ALDH1 and Discovery Purple kit substrate (Ventana) for γH2AX. Slides were counterstained with hematoxylin (Ventana).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!